![Joerg Alte](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joerg Alte
Corporate Officer/Principal en FIDEsprit AG .
Cargos activos de Joerg Alte
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
FIDEsprit AG | Corporate Officer/Principal | 01/09/2007 | - |
Historial de carrera de Joerg Alte
Antiguos cargos conocidos de Joerg Alte.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SANGUI BIOTECH INTERNATIONAL, INC. | Presidente | 01/11/1998 | 01/04/2000 |
PROTEO, INC. | Director/Miembro de la Junta | 01/01/2000 | - |
Estadísticas
Internacional
Estados Unidos | 2 |
Alemania | 2 |
Suiza | 2 |
Operativa
Director/Board Member | 1 |
President | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SANGUI BIOTECH INTERNATIONAL, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Proteo, Inc.
![]() Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA. | Health Technology |
FIDEsprit AG |
- Bolsa de valores
- Insiders
- Joerg Alte
- Experiencia